CA2424623A1 - Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide - Google Patents
Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide Download PDFInfo
- Publication number
- CA2424623A1 CA2424623A1 CA002424623A CA2424623A CA2424623A1 CA 2424623 A1 CA2424623 A1 CA 2424623A1 CA 002424623 A CA002424623 A CA 002424623A CA 2424623 A CA2424623 A CA 2424623A CA 2424623 A1 CA2424623 A1 CA 2424623A1
- Authority
- CA
- Canada
- Prior art keywords
- antacid
- patient
- immunoglobulin
- pooled human
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Selon l'invention, un pool d'immunoglobuline humaine et éventuellement un antiacide peuvent être administrés par voie orale à des patients souffrant d'arthrite rhumatoïde juvénile en vue de traiter l'état pathologique de ces patients. L'administration orale d'un pool d'immunoglobuline humaine conjointement avec un antiacide permet d'obtenir une amélioration clinique marquée en termes de degré d'activité de la maladie chez les patients atteints d'arthrite rhumatoïde juvénile.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68061900A | 2000-10-06 | 2000-10-06 | |
US09/680,619 | 2000-10-06 | ||
PCT/US2001/031240 WO2002028430A2 (fr) | 2000-10-06 | 2001-10-05 | Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2424623A1 true CA2424623A1 (fr) | 2002-04-11 |
Family
ID=24731818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002424623A Abandoned CA2424623A1 (fr) | 2000-10-06 | 2001-10-05 | Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1355665A2 (fr) |
JP (1) | JP2004510748A (fr) |
CA (1) | CA2424623A1 (fr) |
WO (1) | WO2002028430A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002078742A2 (fr) * | 2001-01-30 | 2002-10-10 | The Lauridsen Group, Incorporated | Procedes et compositions destines au traitement de dysfonctions immunitaires |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3272680D1 (en) * | 1981-05-01 | 1986-09-25 | Miles Lab | Oral pharmaceutical composition containing immune globulin |
AU1809495A (en) * | 1994-02-18 | 1995-09-04 | Immuno Aktiengesellschaft | Composition and method for preventing and treating inflammation with immunoglobulin a |
-
2001
- 2001-10-05 JP JP2002532254A patent/JP2004510748A/ja active Pending
- 2001-10-05 WO PCT/US2001/031240 patent/WO2002028430A2/fr not_active Application Discontinuation
- 2001-10-05 CA CA002424623A patent/CA2424623A1/fr not_active Abandoned
- 2001-10-05 EP EP01977531A patent/EP1355665A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002028430A2 (fr) | 2002-04-11 |
EP1355665A2 (fr) | 2003-10-29 |
WO2002028430A3 (fr) | 2003-08-28 |
JP2004510748A (ja) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6294171B2 (en) | Methods for treating disease states comprising administration of low levels of antibodies | |
AU781889B2 (en) | Method for treatment of symptoms of central nervous system disorders | |
US20030099635A1 (en) | Use of oral gammaglobulin for the treatment of immune-mediated diseases | |
Aghamohammadi et al. | Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency | |
US20220002402A1 (en) | Methods of treating graves' ophthalmopathy using anti-fcrn antibodies | |
EP3856243A2 (fr) | Méthodes de traitement de maladies neurodégénératives | |
US6436401B1 (en) | Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies | |
US6090380A (en) | Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin | |
Burakgazi | Immunoglobulin treatment in neuromuscular medicine | |
CA2424623A1 (fr) | Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide | |
CA2370268A1 (fr) | Traitement de la polyarthrite rhumatoide de l'adulte par l'administration orale d'immunoglobuline humaine provenant d'un pool de donneurs et d'un antiacide | |
TW202233234A (zh) | 抗前肌生成抑制蛋白/潛伏性肌生成抑制蛋白抗體用於治療脊髓性肌萎縮之用途 | |
WO2021018191A1 (fr) | Méthode de traitement d'une maladie auto-immune par un antagoniste de l'il-17 | |
RU2772202C2 (ru) | Лечение гнойного гидраденита | |
AU2002248189B2 (en) | Methods for treating disease states comprising administration of low levels of antibodies | |
US4742076A (en) | Etodolac for lowering rheumatoid factor | |
JP2024516019A (ja) | 抗baffr抗体を使用する全身性エリテマトーデスのための治療 | |
RU2197990C2 (ru) | Способ лечения лиц, страдающих от сепсиса | |
WO2007105910A1 (fr) | Composition pharmaceutique pour le traitement de maladies allergiques et de maladies inflammatoires chroniques, et procédé de traitement de maladies allergiques et de maladies inflammatoires chroniques | |
AU2002248189A1 (en) | Methods for treating disease states comprising administration of low levels of antibodies | |
Gravis | CIDPUSA. org Autoimmune diseases | |
Iosifovna | RV Denisova, EI Alexeeva, TV Sleptsova, SI Valieva, TM Bzarova, KB Isaeva, EV Mitenko, EG Chistyakova, AM Chomakhidze, NI Taibulatov, AN Fetisova, OL Lomakina | |
AU2002348464A1 (en) | Gammaglobulin treatment of immune disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20121005 |